Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4095)
All Articles published online
|
Aug 15, 2002 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Fu XY, Wang HY, Tan L, Liu SQ, Cao HF, Wu MC. Overexpression of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i4/638.htm |
| Number | Citing Articles |
| 1 |
Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim. Hepatitis C virus-induced hepatocarcinogenesis. Journal of Hepatology 2009; 51(4): 810 doi: 10.1016/j.jhep.2009.05.008
|
| 2 |
Yu Wang, Han Chong Toh, Pierce Chow, Alexander Y. F. Chung, David J. Meyers, Philip A. Cole, London L. P. J. Ooi, Caroline G. L. Lee. MicroRNA‐224 is up‐regulated in hepatocellular carcinoma through epigenetic mechanisms. The FASEB Journal 2012; 26(7): 3032 doi: 10.1096/fj.11-201855
|
| 3 |
Yun‐Feng Shan, Wei‐Ping Zhou, Xiao‐Yong Fu, He‐Xing Yan, Wen Yang, Shu‐Qin Liu, Hui‐Fang Cao, Bin Kang, Meng‐Chao Wu, Hong‐Yang Wang. The role of p28GANK in rat oval cells activation and proliferation. Liver International 2006; 26(2): 240 doi: 10.1111/j.1478-3231.2005.01203.x
|
| 4 |
Polina Iakova, Lubov Timchenko, Nikolai A. Timchenko. Intracellular signaling and hepatocellular carcinoma. Seminars in Cancer Biology 2011; 21(1): 28 doi: 10.1016/j.semcancer.2010.09.001
|
| 5 |
Alex M. Chapman, Bryce E. Rogers, Brian R. McNaughton. Characterization of the Binding Interaction between the Oncoprotein Gankyrin and a Grafted S6 ATPase. Biochemistry 2014; 53(44): 6857 doi: 10.1021/bi5012354
|
| 6 |
Chun Yang, Ye-xiong Tan, Guang-zhen Yang, Jian Zhang, Yu-fei Pan, Chen Liu, Jing Fu, Yao Chen, Zhi-wen Ding, Li-wei Dong, Hong-yang Wang. Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma. Journal of Experimental Medicine 2016; 213(5): 859 doi: 10.1084/jem.20151208
|
| 7 |
Amber M. D’Souza, Manu Gnanamony, Maria Thomas, Peter Hanley, Dipti Kanabar, Pedro de Alarcon, Aaron Muth, Nikolai Timchenko. Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer. Cancers 2022; 14(13): 3068 doi: 10.3390/cancers14133068
|
| 8 |
María Camacho-Moll, Adriana Sampayo-Reyes, Fabiola Castorena-Torres, Gerardo Lozano-Garza, Gabriela Alarcón-Galván, Alba Hernández, Ricard Marcos, Juan Alcocer-González, Reyes Tamez-Guerra, Mario Bermúdez de León. Selenite Downregulates STAT3 Expression and Provokes Lymphocytosis in the Liver of Chronically Exposed Syrian Golden Hamsters. Molecules 2021; 26(18): 5614 doi: 10.3390/molecules26185614
|
| 9 |
Honghai Li, Xiaoyong Fu, Yao Chen, Yi Hong, Yexiong Tan, Huifang Cao, Mengchao Wu, Hongyang Wang. Use of Adenovirus-Delivered siRNA to Target Oncoprotein p28GANK in Hepatocellular Carcinoma. Gastroenterology 2005; 128(7): 2029 doi: 10.1053/j.gastro.2005.03.001
|
| 10 |
Szymon Krzywda, Andrzej M. Brzozowski, Hiroaki Higashitsuji, Jun Fujita, Rebecca Welchman, Simon Dawson, R.John Mayer, Anthony J. Wilkinson. The Crystal Structure of Gankyrin, an Oncoprotein Found in Complexes with Cyclin-dependent Kinase 4, a 19 S Proteasomal ATPase Regulator, and the Tumor Suppressors Rb and p53. Journal of Biological Chemistry 2004; 279(2): 1541 doi: 10.1074/jbc.M310265200
|
| 11 |
Maria E. Camacho-Moll, Joni Macdonald, L. H. J. Looijenga, Michael P. Rimmer, Roland Donat, John A. Marwick, C. J. Shukla, Neil Carragher, Anne Jørgensen, Rod T. Mitchell. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6340-7
|
| 12 |
Weiguo Ren, Xuexiu Zhang, Qiang Li, Chibin Pu, Decai Zhang, Yuvaraja Teekaraman. Activating IL-6/STAT3 Enhances Protein Stability of Proteasome 20S α+β in Colorectal Cancer by miR-1254. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4250013
|
| 13 |
Tongsen Zheng, Xuehui Hong, Jiabei Wang, Tiemin Pei, Yingjian Liang, Dalong Yin, Ruipeng Song, Xuan Song, Zhaoyang Lu, Shuyi Qi, Jiaren Liu, Boshi Sun, Changming Xie, Shangha Pan, Yuejin Li, Xiaohe Luo, Shuai Li, Xiang Fang, Nishant Bhatta, Hongchi Jiang, Lianxin Liu. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. Hepatology 2014; 59(3): 935 doi: 10.1002/hep.26705
|
| 14 |
Simon P. Dawson. Hepatocellular carcinoma and the ubiquitin–proteasome system. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2008; 1782(12): 775 doi: 10.1016/j.bbadis.2008.08.003
|
| 15 |
Mukund Sudharsan M G, Rupesh Chikhale, Padma P. Nanaware, Somavally Dalvi, Prasanna Venkatraman. A druggable pocket on PSMD10Gankyrin that can accommodate an interface peptide and doxorubicin. European Journal of Pharmacology 2022; 915: 174718 doi: 10.1016/j.ejphar.2021.174718
|
| 16 |
Andrew J. G. Simpson, Otavia L. Caballero, Achim Jungbluth, Yao-Tseng Chen, Lloyd J. Old. Cancer/testis antigens, gametogenesis and cancer. Nature Reviews Cancer 2005; 5(8): 615 doi: 10.1038/nrc1669
|
| 17 |
Khalil Hajiasgharzadeh, Mohammad Hossein Somi, Dariush Shanehbandi, Ahad Mokhtarzadeh, Behzad Baradaran. Small interfering RNA–mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(4): 3263 doi: 10.1002/jcp.27015
|
| 18 |
Toshikazu Nagao, Hiroaki Higashitsuji, Kohsuke Nonoguchi, Toshiharu Sakurai, Simon Dawson, R. John Mayer, Katsuhiko Itoh, Jun Fujita. MAGE-A4 Interacts with the Liver Oncoprotein Gankyrin and Suppresses Its Tumorigenic Activity. Journal of Biological Chemistry 2003; 278(12): 10668 doi: 10.1074/jbc.M206104200
|
| 19 |
Yuan Liu, Jiawen Zhang, Wenyan Qian, Yu Dong, Yongbin Yang, Zhiqiang Liu, Youji Feng, Ding Ma, Zhenbo Zhang, Sufang Wu, Javier S. Castresana. Gankyrin Is Frequently Overexpressed in Cervical High Grade Disease and Is Associated with Cervical Carcinogenesis and Metastasis. PLoS ONE 2014; 9(4): e95043 doi: 10.1371/journal.pone.0095043
|
| 20 |
Desirée Bartolini, Katiuscia Dallaglio, Pierangelo Torquato, Marta Piroddi, Francesco Galli. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma. Translational Research 2018; 193: 54 doi: 10.1016/j.trsl.2017.11.007
|
| 21 |
Yang Yang, Chunli Zhang, Li Li, Yusong Gao, Xinming Luo, Yadong Zhang, Weiping Liu, Zhou Fei. Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-169
|
| 22 |
Joan Oliva, Fawzia Bardag-Gorce, Barbara A. French, Jun Li, Samuel W. French. The regulation of non-coding RNA expression in the liver of mice fed DDC. Experimental and Molecular Pathology 2009; 87(1): 12 doi: 10.1016/j.yexmp.2009.03.006
|
| 23 |
Yu Wang, Caroline GL Lee. Role of miR-224 in Hepatocellular Carcinoma: A Tool for Possible Therapeutic Intervention?. Epigenomics 2011; 3(2): 235 doi: 10.2217/epi.11.5
|
| 24 |
Yun Meng, Lijie He, Xuegang Guo, Shanhong Tang, Xiaodi Zhao, Rui Du, Jiang Jin, Qian Bi, Hao Li, Yongzhan Nie, Jie liu, Daiming Fan. Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Letters 2010; 297(1): 9 doi: 10.1016/j.canlet.2010.04.019
|
| 25 |
Patrick Arbuthnot, Liam Jed Thompson. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1670-1681 doi: 10.3748/wjg.14.1670
|
| 26 |
Alex M. Chapman, Brian R. McNaughton. Resurfaced Shape Complementary Proteins That Selectively Bind the Oncoprotein Gankyrin. ACS Chemical Biology 2014; 9(10): 2223 doi: 10.1021/cb5003834
|
| 27 |
LIUCUN GAO, HUAHONG XIE, LIHOU DONG, JIA ZOU, JIE FU, XIN GAO, LUN OU, SHENSI XIANG, HAIFENG SONG. Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells. Molecular Medicine Reports 2014; 9(3): 1032 doi: 10.3892/mmr.2013.1860
|
| 28 |
Satoshi Ando, Taeko Matsuoka, Koji Kawai, Shintaro Sugita, Akira Joraku, Takahiro Kojima, Takahiro Suetomi, Jun Miyazaki, Jun Fujita, Hiroyuki Nishiyama. Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor. International Journal of Urology 2014; 21(10): 992 doi: 10.1111/iju.12484
|
| 29 |
Azhwar Raghunath, Kiruthika Sundarraj, Frank Arfuso, Gautam Sethi, Ekambaram Perumal. Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance. Cancers 2018; 10(12): 481 doi: 10.3390/cancers10120481
|
| 30 |
Zhaofang Bai, Yanhong Tai, Weihua Li, Cheng Zhen, Weiting Gu, Zhao Jian, Qianyi Wang, Jieru E. Lin, Qing Zhao, Weili Gong, Bing Liang, Chenguang Wang, Tao Zhou. Gankyrin Activates IL-8 to Promote Hepatic Metastasis of Colorectal Cancer. Cancer Research 2013; 73(14): 4548 doi: 10.1158/0008-5472.CAN-12-4586
|
| 31 |
Parvin Zamani, Maryam Matbou Riahi, Amir Abbas Momtazi-Borojeni, Khadijeh Jamialahmadi. Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 2018; 46(7): 1301 doi: 10.1080/21691401.2017.1388250
|
| 32 |
|
| 33 |
Xiaohua Li, Ying Zhang, Chen Xiong, Haifeng Jin, Bin Jing, Yafei Zhang, Daiming Fan. Overexpression of a New Gene p28GANK Confers Multidrug Resistance of Gastric Cancer Cells. Cancer Investigation 2009; 27(2): 129 doi: 10.1080/07357900802189816
|
| 34 |
Atsushi Umemura, Yoshito Itoh, Katsuhiko Itoh, Kanji Yamaguchi, Tomoki Nakajima, Hiroaki Higashitsuji, Hitoshi Onoue, Manabu Fukumoto, Takeshi Okanoue, Jun Fujita. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology 2008; 47(2): 493 doi: 10.1002/hep.22027
|
| 35 |
H F Horn, K H Vousden. Coping with stress: multiple ways to activate p53. Oncogene 2007; 26(9): 1306 doi: 10.1038/sj.onc.1210263
|
| 36 |
Jian-Min Qin, Xiao-Yong Fu, Shen-Jing Li, Shu-Qin Liu, Jin-Zhang Zeng, Xiu-Hua Qiu, Meng-Chao Wu, Hong-Yang Wang. Gene and protein expressions of p28<sup>GANK</sup> in rat with liver regeneration. World Journal of Gastroenterology 2003; 9(11): 2523-2527 doi: 10.3748/wjg.v9.i11.2523
|
| 37 |
R.J. Mayer, J. Fujita. Gankyrin, the 26 S proteasome, the cell cycle and cancer. Biochemical Society Transactions 2006; 34(5): 746 doi: 10.1042/BST0340746
|
| 38 |
Jing Fu, Yao Chen, Jie Cao, Tao Luo, You-Wen Qian, Wen Yang, Yi-Bin Ren, Bo Su, Guang-Wen Cao, Yuan Yang, Yi-Qun Yan, Feng Shen, Meng-Chao Wu, Gen-Sheng Feng, Hong-Yang Wang. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology 2011; 53(1): 181 doi: 10.1002/hep.24015
|
| 39 |
Ru-Lin Cai, Wei Meng, Hong-Yan Lu, Wen-Yao Lin, Feng Jiang, Fu-Min Shen. Segregation analysis of hepatocellular carcinoma in a moderately high-incidence area of East China. World Journal of Gastroenterology 2003; 9(11): 2428-2432 doi: 10.3748/wjg.v9.i11.2428
|
| 40 |
Ming Lei, Yun-Long Zhang, Feng-Ying Huang, Heng-Yu Chen, Ming-Hui Chen, Ri-Hong Wu, Shu-Zhen Dai, Gui-Sheng He, Guang-Hong Tan, Wu-Ping Zheng. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-49136-8
|
| 41 |
Wen Sun, Jin Ding, Kun Wu, Bei-Fang Ning, Wen Wen, Han-Yong Sun, Tao Han, Lei Huang, Li-Wei Dong, Wen Yang, Xing Deng, Zhong Li, Meng-Chao Wu, Gen-Sheng Feng, Wei-Fen Xie, Hong-Yang Wang. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology 2011; 54(4): 1259 doi: 10.1002/hep.24530
|
| 42 |
Padma P. Nanaware, Manoj P. Ramteke, Arun K. Somavarapu, Prasanna Venkatraman. Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein—Evidence for a common hot spot site at the interface and its functional relevance. Proteins: Structure, Function, and Bioinformatics 2014; 82(7): 1283 doi: 10.1002/prot.24494
|
| 43 |
Hongbiao Jing, Guoming Zhang, Lingsheng Meng, Qingda Meng, Haiying Mo, Yanhong Tai. Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance. Scientific Reports 2014; 4(1) doi: 10.1038/srep05503
|
| 44 |
Li-Hua Chen, Xue-Song Liu, Wen-Yong Wang, Wei-Ning Han, Bo-Rong Pan, Bo-Quan Jin. Localization of TRAIL/TRAILR in fetal pancreas. World Journal of Gastroenterology 2003; 9(2): 334-337 doi: 10.3748/wjg.v9.i2.334
|
| 45 |
Ju-Ae Hwang, Heung-Mo Yang, Doo-Pyo Hong, Sung-Yeon Joo, Yoon-La Choi, Joo-Hung Park, Alexander J. Lazar, Raphael E. Pollock, Dina Lev, Sung Joo Kim. Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma. Oncotarget 2014; 5(19): 9065 doi: 10.18632/oncotarget.2375
|
| 46 |
Antonia A. Nemec, Anna K. Peterson, Jennifer L. Warnock, Randi G. Reed, Robert J. Tomko. An Allosteric Interaction Network Promotes Conformation State-Dependent Eviction of the Nas6 Assembly Chaperone from Nascent 26S Proteasomes. Cell Reports 2019; 26(2): 483 doi: 10.1016/j.celrep.2018.12.042
|
| 47 |
Peipei Hao, Fengming Yue, Xian Xian, Qian Ren, Huixian Cui, Yunpeng Wang. Inhibiting effect of MicroRNA-3619-5p/PSMD10 axis on liver cancer cell growth in vivo and in vitro. Life Sciences 2020; 254: 117632 doi: 10.1016/j.lfs.2020.117632
|
| 48 |
Tai-Chung Huang, Santosh Renuse, Sneha Pinto, Praveen Kumar, Yi Yang, Raghothama Chaerkady, Brian Godsey, Joshua T. Mendell, Marc K. Halushka, Curt I. Civin, Luigi Marchionni, Akhilesh Pandey. Identification of miR-145 targets through an integrated omics analysis. Molecular BioSystems 2015; 11(1): 197 doi: 10.1039/C4MB00585F
|
| 49 |
Lu Tan, Xiao‐Yong Fu, Shu‐Qin Liu, Hong‐Hai Li, Yi Hong, Meng‐Chao Wu, Hong‐Yang Wang. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma. Liver International 2005; 25(3): 667 doi: 10.1111/j.1478-3231.2005.01003.x
|
| 50 |
Yanjun Jiang, Polina Iakova, Jingling Jin, Emily Sullivan, Vladislav Sharin, Il-Hwa Hong, Sayee Anakk, Angela Mayor, Gretchen Darlington, Milton Finegold, David Moore, Nikolai A. Timchenko. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology 2013; 57(3): 1098 doi: 10.1002/hep.26146
|
| 51 |
Marie C. DeFrances, George K. Michalopoulos. Hepatocellular Cancer. 2005; : 23 doi: 10.1007/978-1-59259-844-1_2
|
| 52 |
Anjali Mahajan, Yi Guo, Chunhua Yuan, Christopher M. Weghorst, Ming-Daw Tsai, Junan Li. Dissection of Protein–Protein Interaction and CDK4 Inhibition in the Oncogenic versus Tumor Suppressing Functions of Gankyrin and P16. Journal of Molecular Biology 2007; 373(4): 990 doi: 10.1016/j.jmb.2007.08.038
|
| 53 |
Y.B. Ren, T. Luo, J. Li, J. Fu, Q. Wang, G.W. Cao, Y. Chen, H.Y. Wang. p28GANK associates with p300 to attenuate the acetylation of RelA. Molecular Carcinogenesis 2015; 54(12): 1626 doi: 10.1002/mc.22235
|
| 54 |
Lih-Hwa Hwang. Gene Therapy Strategies for Hepatocellular Carcinoma. Journal of Biomedical Science 2006; 13(4): 453 doi: 10.1007/s11373-006-9085-7
|
| 55 |
Raphaël Saffroy, Patrick Pham, Maâmar Reffas, Mohamed Takka, Antoinette Lemoine, Brigitte Debuire. New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clinical Chemical Laboratory Medicine 2007; 45(9) doi: 10.1515/CCLM.2007.262
|
| 56 |
Rong-Yang Dai, Yao Chen, Jing Fu, Li-Wei Dong, Yi-Bin Ren, Guang-Zhen Yang, You-Wen Qian, Jie Cao, Shan-Hua Tang, Sheng-Li Yang, Hong-Yang Wang. p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity. Cell Research 2009; 19(11): 1243 doi: 10.1038/cr.2009.104
|
| 57 |
Dharmendra Kashyap, Budhadev Baral, Shweta Jakhmola, Anil Kumar Singh, Hem Chandra Jha, Blossom Damania. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin. mSphere 2021; 6(5) doi: 10.1128/mSphere.00751-21
|
| 58 |
Alex M. Chapman, Brian R. McNaughton. Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53. ACS Chemical Biology 2015; 10(8): 1880 doi: 10.1021/acschembio.5b00201
|
| 59 |
Meng-Sen Li, Ping-Feng Li, Qian Chen, Guo-Guang Du, Gang Li. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. World Journal of Gastroenterology 2004; 10(6): 819-824 doi: 10.3748/wjg.v10.i6.819
|
| 60 |
Annesa Flentje, Kord M. Kober, Adam W. Carrico, Torsten B. Neilands, Elena Flowers, Nicholas C. Heck, Bradley E. Aouizerat. Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection. Brain, Behavior, and Immunity 2018; 70: 335 doi: 10.1016/j.bbi.2018.03.016
|
| 61 |
Dharmendra Kashyap, Nidhi Varshney, Hamendra Singh Parmar, Hem Chandra Jha. Gankyrin: At the crossroads of cancer diagnosis, disease prognosis, and development of efficient cancer therapeutics. Advances in Cancer Biology - Metastasis 2022; 4: 100023 doi: 10.1016/j.adcanc.2021.100023
|
| 62 |
Levan Gogichaishvili, Gia Lobzhanidze, Hans Schlit, Zanda Bedinashvili, Lali Sharvadze, Nana Goishvili, Mikheil Jangavadze. Assessment of gankyrin mRNA expression in tissue and liquid biopsy as a sensitive biomarker for hepatocellular carcinoma. World Academy of Sciences Journal 2024; 6(1) doi: 10.3892/wasj.2024.221
|
| 63 |
Christine S. Muli, Wenzhi Tian, Darci J. Trader. Small‐Molecule Inhibitors of the Proteasome's Regulatory Particle. ChemBioChem 2019; 20(14): 1739 doi: 10.1002/cbic.201900017
|
| 64 |
Carmen Chak-Lui Wong, Alan Ka-Lun Kai, Irene Oi-Lin Ng. The impact of hypoxia in hepatocellular carcinoma metastasis. Frontiers of Medicine 2014; 8(1): 33 doi: 10.1007/s11684-013-0301-3
|
| 65 |
Viktoria N Evdokimova, Lisa H Butterfield. α-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer. Expert Opinion on Biological Therapy 2008; 8(3): 325 doi: 10.1517/14712598.8.3.325
|
| 66 |
Wu-ping Wang, Xiao-long Yan, Wei-Miao Li, Yun-feng Ni, Jin-bo Zhao, Qiang Lu, Xue-jiao Wang, Ying Sun, Peng Chen, Bing-yang Yan, Yuanbo Cui, Zhi-Pei Zhang, Xiao-Fei Li. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Pathology - Research and Practice 2015; 211(12): 939 doi: 10.1016/j.prp.2015.09.010
|
| 67 |
Jiaren Sun, Gaurav Chaturvedi, Steven A. Weinman. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 569 doi: 10.1007/978-1-4419-7107-4_38
|